Sheng Ding

Dr. Ding is the William K. Bowes, Jr. Distinguished Investigator at the Gladstone Institute of Cardiovascular Disease, and a professor in the Department of Pharmaceutical Chemistry at the University of California, San Francisco (UCSF). He received his B.S. in chemistry with honors from Caltech and a Ph.D. in chemistry from The Scripps Research Institute. Before moving to Gladstone/UCSF in early 2011, Dr. Ding was an assistant professor and then associate professor of chemistry at Scripps. Dr. Ding has pioneered the development and application of innovative chemical approaches to stem cell biology and regeneration, with a focus on discovering and characterizing novel small molecules that can control various cell fate/function, including stem cell maintenance, activation, differentiation and reprogramming in various developmental stages and tissues. Dr. Ding has published over 130 research articles, reviews and book chapters, has over 30 patents and has made several seminal contributions to the stem cell field. He is a co-founder of several biotech companies.